Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Alboreggia

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Research Square|April 8, 2025
A fragment-based electrophile-first approach to target histidine with aryl-fluorosulfates: application to hMcl-1Giulia Alboreggia, Kendall Muzzarelli, Zahra Assar, et al.
Journal of Medicinal Chemistry|November 12, 2025
A Fragment-Based Electrophile-First Approach to Target Histidine with Aryl-Fluorosulfates: Application to hMcl-1Giulia Alboreggia, Kendall Muzzarelli, Zahra Assar, et al.
Journal of Medicinal Chemistry|July 19, 2023
Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, et al.
Journal of Medicinal Chemistry|October 27, 2021
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis ProteinParima Udompholkul, Carlo Baggio, Luca Gambini, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2024
Targeted degradation of Pin1 by protein-destabilizing compoundsGiulia Alboreggia, Parima Udompholkul, Isaac Rodriguez, et al.
Journal of Medicinal Chemistry|April 29, 2026
Covalent Targeting of Histidine Residues: A Ligand-First ApproachGiulia Alboreggia, Emma L Atienza, Kendall Muzzarelli, et al.
Journal of Medicinal Chemistry|May 2, 2024
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, et al.
Journal of Medicinal Chemistry|November 12, 2024
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 MimeticsGiulia Alboreggia, Parima Udompholkul, Emma L Atienza, et al.
Journal of Medicinal Chemistry|June 1, 2023
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) AntagonistParima Udompholkul, Ana Garza-Granados, Giulia Alboreggia, et al.
Molecular Therapy. Oncology|December 1, 2025
Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancerGiulia Alboreggia, Tiane Li, Anne Marie Prentiss, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Research Square|April 8, 2025
A fragment-based electrophile-first approach to target histidine with aryl-fluorosulfates: application to hMcl-1Giulia Alboreggia, Kendall Muzzarelli, Zahra Assar, et al.
Journal of Medicinal Chemistry|November 12, 2025
A Fragment-Based Electrophile-First Approach to Target Histidine with Aryl-Fluorosulfates: Application to hMcl-1Giulia Alboreggia, Kendall Muzzarelli, Zahra Assar, et al.
Journal of Medicinal Chemistry|July 19, 2023
Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, et al.
Journal of Medicinal Chemistry|October 27, 2021
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis ProteinParima Udompholkul, Carlo Baggio, Luca Gambini, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2024
Targeted degradation of Pin1 by protein-destabilizing compoundsGiulia Alboreggia, Parima Udompholkul, Isaac Rodriguez, et al.
Journal of Medicinal Chemistry|April 29, 2026
Covalent Targeting of Histidine Residues: A Ligand-First ApproachGiulia Alboreggia, Emma L Atienza, Kendall Muzzarelli, et al.
Journal of Medicinal Chemistry|May 2, 2024
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, et al.
Journal of Medicinal Chemistry|November 12, 2024
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 MimeticsGiulia Alboreggia, Parima Udompholkul, Emma L Atienza, et al.
Journal of Medicinal Chemistry|June 1, 2023
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) AntagonistParima Udompholkul, Ana Garza-Granados, Giulia Alboreggia, et al.
Molecular Therapy. Oncology|December 1, 2025
Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancerGiulia Alboreggia, Tiane Li, Anne Marie Prentiss, et al.
Pageof 2